TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Nordic Bioscience A/S
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
515,952
|
356,556
|
443,872 |
| Earnings before taxes |
161,334
|
64,865
|
195,498 |
| Total assets |
675,460
|
439,125
|
384,839 |
| Current assets |
549,685
|
308,233
|
265,209 |
| Current liabilities |
434,229
|
281,237
|
219,484 |
| Equity capital |
176,659
|
92,902
|
101,448 |
| - share capital |
15,879
|
15,082
|
14,155 |
| Employees (average) |
150
|
150
|
150 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
26.2%
|
21.2%
|
26.4% |
| Turnover per employee |
3,440
|
2,377
|
2,959 |
| Profit as a percentage of turnover |
31.3%
|
18.2%
|
44.0% |
| Return on assets (ROA) | |||
| Current ratio |
126.6%
|
109.6%
|
120.8% |
| Return on equity (ROE) |
91.3%
|
69.8%
|
192.7% |
| Change turnover |
140,550
|
-116,376
|
60,240 |
| Change turnover % |
37%
|
-25%
|
16% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.